HpVac is an ambitious biotechnology start-up specializing in the development of novel treatments for allergic diseases based on immunomodulatory proteins produced by the human microbiota. The team at the HpVac is a small close-knit group of experts in preclinical & clinical development, sales, marketing, legal and finance. HpVac will be considering bolstering its team with an experienced immunologist to diversify and strengthen the expertise within the group.